Logo
Daily Brief
Following
Why
FR

FDA Center for Drug Evaluation and Research

Federal Regulatory Agency

Appears in 2 stories

Stories

Race for First EBV+ PTLD Therapy Nears Finish Line

Race for First EBV+ PTLD Therapy Nears Finish Line

Reviewing resubmitted BLA under priority review

New Capabilities ongoing
The BTK Inhibitor Race for Multiple Sclerosis

The BTK Inhibitor Race for Multiple Sclerosis

Reviewing BTK inhibitor safety across multiple programs

New Capabilities ongoing